India's consumer goods and healthcare sectors are poised for robust growth this fiscal year, driven by tax relief, increasing consumer spen...

Telecom operators are poised for single-digit revenue growth this quarter, driven by steady subscriber additions and users opting for premi...

Indian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...

Indian consumer goods giants Dabur and Godrej Consumer Products reported resilient demand in early fiscal 2027, defying geopolitical worrie...

Godrej Consumer anticipates a robust first quarter, projecting high-teen consolidated revenue growth driven by solid underlying volume incr...

Nestle India's Chairman highlighted how food inflation reshaped consumer choices, impacting pack sizes and purchase habits in FY26. Despite...

India's consumer goods and healthcare sectors are poised for strong growth this fiscal year, fueled by tax cuts, rising consumer demand, an...

Swara Baby has filed its DRHP with Sebi for a Rs 1,000 crore IPO, comprising a Rs 500 crore fresh issue and Rs 500 crore OFS. The hygiene p...

India's GST revenue surged 13.9% to ₹1.95 lakh crore in June, driven by a significant 34.6% jump in import tax collections. While domestic ...

A delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...

During the second half of FY26, PayU India also exited certain "negative margin portfolios", impacting its sequential revenue growth. In th...

Indian auto ancillaries witnessed robust revenue growth of 12.5% in FY26, driven by strong volumes and a better product mix. While EBITDA a...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

Indian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...